Allogeneic Serum Eye Drops for the Treatment of Severe Dry Eye in Patients With Chronic Graft-Versus-Host Disease

Purpose: To describe the use of allogeneic serum eye drops to treat 2 patients with chronic graft-versus-host disease (GVHD)-induced severe ocular surface disease. Methods: Small case series. Results: Conventional therapy failed to control the ocular symptoms of 2 patients with GVHD who presented with severe dry eye syndrome. Because autologous serum was unavailable in these cases, we used allogeneic serum eye drops as an alternate option for treating their ocular surface disease. Both donors had serologic tests performed before donation. Use of the allogeneic serum eye drops had a beneficial clinical effect, with marked attenuation of the patients' symptoms. This therapy proved to be safe during 10 months of treatment. Conclusions: Allogeneic serum eye drops may be a good alternative treatment for patients with severe dry eyes caused by GVHD.

[1]  A. Tarkkanen,et al.  Epidermal growth factor is a constant component of normal human tear fluid , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  K. Tsubota,et al.  Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease , 2003, Bone Marrow Transplantation.

[3]  A. Vigorito,et al.  GVHD dry eyes treated with autologous serum tears , 2000, Bone Marrow Transplantation.

[4]  J. Eberle,et al.  HIV-1 infection transmitted by serum droplets into the eye: a case report. , 2000, AIDS.

[5]  K. Tsubota,et al.  Important concepts for treating ocular surface and tear disorders. , 1997, American journal of ophthalmology.

[6]  S. Pflugfelder,et al.  Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland. , 1996, Current eye research.

[7]  S. Wilson,et al.  Basic fibroblast growth factor (FGFb) and epidermal growth factor (EGF) receptor messenger RNA production in human lacrimal gland. , 1991, Investigative ophthalmology & visual science.

[8]  S Kinoshita,et al.  Presence of epidermal growth factor in human tears. , 1989, Investigative ophthalmology & visual science.

[9]  J. Ubels,et al.  Retinol secretion by the lacrimal gland. , 1986, Investigative ophthalmology & visual science.

[10]  C. Robinson,et al.  Sjögren's syndrome. Proposed criteria for classification. , 1986, Arthritis and rheumatism.

[11]  J. Belmont,et al.  Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. , 1984, Arthritis and rheumatism.